|
Volumn 91, Issue , 1997, Pages 73-78
|
In-process testing and limits.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BACTERIAL DNA;
DNA;
RECOMBINANT PROTEIN;
ANIMAL;
BIOTECHNOLOGY;
DRUG CONTAMINATION;
DRUG INDUSTRY;
DRUG SCREENING;
EUROPE;
GENETICS;
ISOLATION AND PURIFICATION;
MAMMAL;
METHODOLOGY;
MICROBIOLOGY;
ORGANIZATION AND MANAGEMENT;
PHARMACEUTICS;
PRACTICE GUIDELINE;
QUALITY CONTROL;
REVIEW;
STANDARD;
SWEDEN;
TOTAL QUALITY MANAGEMENT;
ANIMALS;
BIOPHARMACEUTICS;
BIOTECHNOLOGY;
DNA;
DNA, BACTERIAL;
DRUG CONTAMINATION;
DRUG EVALUATION;
DRUG INDUSTRY;
EUROPE;
GUIDELINES;
INDUSTRIAL MICROBIOLOGY;
MAMMALS;
QUALITY CONTROL;
RECOMBINANT PROTEINS;
SWEDEN;
TOTAL QUALITY MANAGEMENT;
|
EID: 0031298669
PISSN: 03015149
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (4)
|
References (0)
|